Market
BD reports FY26 revenues of $19.5bn after medtech prioritisation
BD reported fiscal 2026 revenues of $19.5 billion following its June 2025 spin-out of its diagnostics business to Waters Corporation in a $17.5 billion transaction. The divestiture realigns the company's portfolio toward medical technology and surgical devices.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network